PELI2_HUMAN - dbPTM
PELI2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID PELI2_HUMAN
UniProt AC Q9HAT8
Protein Name E3 ubiquitin-protein ligase pellino homolog 2
Gene Name PELI2
Organism Homo sapiens (Human).
Sequence Length 420
Subcellular Localization
Protein Description E3 ubiquitin ligase catalyzing the covalent attachment of ubiquitin moieties onto substrate proteins. Involved in the TLR and IL-1 signaling pathways via interaction with the complex containing IRAK kinases and TRAF6. Mediates IL1B-induced IRAK1 'Lys-63'-linked polyubiquitination and possibly 'Lys-48'-linked ubiquitination. May be important for LPS- and IL1B-induced MAP3K7-dependent, but not MAP3K3-dependent, NF-kappa-B activation. Can activate the MAP (mitogen activated protein) kinase pathway leading to activation of ELK1..
Protein Sequence MFSPGQEEHCAPNKEPVKYGELVVLGYNGALPNGDRGRRKSRFALYKRPKANGVKPSTVHVISTPQASKAISCKGQHSISYTLSRNQTVVVEYTHDKDTDMFQVGRSTESPIDFVVTDTISGSQNTDEAQITQSTISRFACRIVCDRNEPYTARIFAAGFDSSKNIFLGEKAAKWKNPDGHMDGLTTNGVLVMHPRGGFTEESQPGVWREISVCGDVYTLRETRSAQQRGKLVESETNVLQDGSLIDLCGATLLWRTADGLFHTPTQKHIEALRQEINAARPQCPVGLNTLAFPSINRKEVVEEKQPWAYLSCGHVHGYHNWGHRSDTEANERECPMCRTVGPYVPLWLGCEAGFYVDAGPPTHAFTPCGHVCSEKSAKYWSQIPLPHGTHAFHAACPFCATQLVGEQNCIKLIFQGPID
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
3Phosphorylation-----MFSPGQEEHC
-----CCCCCCCCCC
27.16-
36MethylationGALPNGDRGRRKSRF
CCCCCCCCCCCCCCE
41.7581452627
38MethylationLPNGDRGRRKSRFAL
CCCCCCCCCCCCEEE
43.69115388779
47UbiquitinationKSRFALYKRPKANGV
CCCEEEECCCCCCCC
64.17-
50AcetylationFALYKRPKANGVKPS
EEEECCCCCCCCCCC
59.527965575
55AcetylationRPKANGVKPSTVHVI
CCCCCCCCCCEEEEE
34.357965585
63PhosphorylationPSTVHVISTPQASKA
CCEEEEEECCCCCCC
32.7128555341
64PhosphorylationSTVHVISTPQASKAI
CEEEEEECCCCCCCC
14.32-
69UbiquitinationISTPQASKAISCKGQ
EECCCCCCCCCCCCE
53.40-
74UbiquitinationASKAISCKGQHSISY
CCCCCCCCCEEEEEE
55.61-
78PhosphorylationISCKGQHSISYTLSR
CCCCCEEEEEEEECC
12.8230576142
80PhosphorylationCKGQHSISYTLSRNQ
CCCEEEEEEEECCCC
18.3230576142
81PhosphorylationKGQHSISYTLSRNQT
CCEEEEEEEECCCCE
15.27-
82PhosphorylationGQHSISYTLSRNQTV
CEEEEEEEECCCCEE
16.0930576142
84PhosphorylationHSISYTLSRNQTVVV
EEEEEEECCCCEEEE
22.76-
88PhosphorylationYTLSRNQTVVVEYTH
EEECCCCEEEEEEEC
20.8628555341
151PhosphorylationVCDRNEPYTARIFAA
ECCCCCCEEEEEEEE
13.5725839225
164UbiquitinationAAGFDSSKNIFLGEK
EEECCCCCCEECCHH
59.00-
171UbiquitinationKNIFLGEKAAKWKNP
CCEECCHHHHCCCCC
52.42-
176AcetylationGEKAAKWKNPDGHMD
CHHHHCCCCCCCCCC
58.8719608861
219PhosphorylationSVCGDVYTLRETRSA
EEECCEEEHHHCCHH
21.1324719451
235PhosphorylationQRGKLVESETNVLQD
HHCCEEECCCCCCCC
42.0929978859
237PhosphorylationGKLVESETNVLQDGS
CCEEECCCCCCCCCC
39.6529978859
244PhosphorylationTNVLQDGSLIDLCGA
CCCCCCCCCHHHCCC
30.3729978859
252PhosphorylationLIDLCGATLLWRTAD
CHHHCCCEEEEECCC
13.9929978859
257PhosphorylationGATLLWRTADGLFHT
CCEEEEECCCCCCCC
19.9529978859
264PhosphorylationTADGLFHTPTQKHIE
CCCCCCCCCHHHHHH
22.2429978859
266PhosphorylationDGLFHTPTQKHIEAL
CCCCCCCHHHHHHHH
51.9429978859
268UbiquitinationLFHTPTQKHIEALRQ
CCCCCHHHHHHHHHH
49.37-
290PhosphorylationQCPVGLNTLAFPSIN
CCCCCCCCEECCCCC
25.2230576142
295PhosphorylationLNTLAFPSINRKEVV
CCCEECCCCCHHHHH
26.4930576142

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
290TPhosphorylationKinaseIRAK1P51617
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of PELI2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of PELI2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
IRAK1_HUMANIRAK1physical
17675297
IRAK4_HUMANIRAK4physical
12860405
IRAK1_HUMANIRAK1physical
12860405
IRAK1_HUMANIRAK1physical
15917247
TRAF6_HUMANTRAF6physical
12804775
NR2C2_HUMANNR2C2physical
12804775
PICAL_HUMANPICALMphysical
21988832
THAP7_HUMANTHAP7physical
21988832
IRAK1_HUMANIRAK1physical
25027698
UCRI_HUMANUQCRFS1physical
25027698
TRAF6_HUMANTRAF6physical
25027698

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of PELI2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-176, AND MASS SPECTROMETRY.

TOP